Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Viana Do Castelo – page 5

248 clinical trials in Viana Do Castelo, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Viana Do Castelo at a glance
248
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

248 trials in Viana Do Castelo

Open in trial search

A Study of Amivantamab and Lazertinib for Adults with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen Cilag International

Osteoarthritis

Recruiting

A study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Montelukast
  • Sponsor:Farmalider S.A.

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:F. Hoffmann-La Roche AG

Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Novartis Pharma AG

Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Loperamide Hydrochloride
  • Sponsor:Biocodex

Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ficerafusp alfa
  • Sponsor:Bicara Therapeutics Inc.

IgA nephropathy

Recruiting

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Biogen Idec Research Limited

Study of telisotuzumab adizutecan with osimertinib as first treatment for adults with advanced or metastatic EGFR-mutated non-small cell lung cancer

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Multiple sclerosis+1

Recruiting

Study on the Effects of THC and CBD Oral Solution for Chronic Neuropathic Pain in Multiple Sclerosis Patients

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Cannabidiol
  • Sponsor:Ferraz Lynce Especialidades Farmaceuticas S.A.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Viana Do Castelo

What the registry says about research in the country

01 Autoimmune Disorders

Investigating innovative treatments for various autoimmune conditions, including Primary Sjögren's Syndrome and Lupus Erythematosus. Research focuses on evaluating new therapeutic agents for managing systemic and cutaneous manifestations.

  • Sjögren's Disease Management
  • Cutaneous Lupus Treatment
  • Psoriatic Arthritis Therapy

Studies aim to improve disease control and patient quality of life through targeted interventions.

02 Gastrointestinal Disorders

Clinical research examining treatments for inflammatory bowel conditions and digestive disorders, including Crohn's Disease and Ulcerative Colitis. Studies evaluate long-term efficacy of novel therapeutic approaches.

  • Inflammatory Bowel Disease Management
  • Post-Gastrectomy Care
  • Pancreatic Enzyme Therapy

Investigations focus on improving treatment outcomes and disease management strategies.

03 Metabolic and Liver Conditions

Comprehensive research into Non-alcoholic Steatohepatitis (NASH) and metabolic disorders, including Type 2 Diabetes. Studies evaluate innovative treatments and combination therapies.

  • NASH Treatment Development
  • Diabetes Management Optimization
  • Liver Disease Interventions

Research aims to address both disease progression and symptom management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.